J Stirnemann. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » 1-Deoxynojirimycin/analogs & derivatives1-Deoxynojirimycin/therapeutic useClinical ProtocolsClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicEnzyme Inhibitors/therapeutic useGaucher Disease/classificationGaucher Disease/drug therapyGaucher Disease/geneticsGlucosylceramidase/therapeutic useHumansPhenotypeRecombinant Proteins/therapeutic use
Substances： See more » Enzyme InhibitorsRecombinant Proteins1-DeoxynojirimycinmiglustatGlucosylceramidaseimiglucerase
Year: 2007 PMID： 17964006 DOI： 10.1016/j.revmed.2007.09.005
Source DB: PubMed Journal: Rev Med Interne ISSN： 0248-8663 Impact factor: 0.728